Compugen reported $626.04M in Market Capitalization this March of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Arca Biopharma USD 384M 295M Mar/2025
aTyr Pharma USD 71M 63M Sep/2025
Bio Path USD 1000K 4M Mar/2025
Brainstorm Cell Therapeutics USD 10M 4M Mar/2025
Cara Therapeutics USD 28M 11M Dec/2024
Clal Biotechnology ILS 47.99M 4.37M Jan/2026
Compugen USD 137.5M 21.89M Sep/2025
Infinity Pharmaceuticals USD 19M 5M Jun/2023
RedHill Biopharma USD 12M 17M Jun/2024